PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.69%
Negative net income growth while MCHP stands at 8.19%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-34.71%
Both reduce yoy D&A, with MCHP at -3.42%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
61.29%
Lower deferred tax growth vs. MCHP's 127.02%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
-378.08%
Negative yoy working capital usage while MCHP is 54.80%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
50.43%
Inventory growth well above MCHP's 98.14%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-200.00%
Negative yoy usage while MCHP is 6.50%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
23.08%
Lower 'other non-cash' growth vs. MCHP's 601.48%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-38.66%
Negative yoy CFO while MCHP is 64.15%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-17.92%
Both yoy lines negative, with MCHP at -87.62%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-17600.00%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
57.02%
Purchases well above MCHP's 63.36%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
23.51%
We have some liquidation growth while MCHP is negative at -57.40%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
152.54%
Investing outflow well above MCHP's 70.19%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-2.07%
Negative yoy issuance while MCHP is 51.34%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-65.52%
We cut yoy buybacks while MCHP is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.